Susan Jenkins, MD
Gynecology · Largo, MDNPI 1942299417
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,640 of the $2,263 with a category attached, or 72.5%. 13 manufacturers reported payments, led by Scynexis, Inc. at 51.1% of the total. Reporting peaked in 2022 at $1,275 and has fallen 96.8% since, to $41 in 2025.
Across 30 payments — averaging $75.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scynexis, Inc.$1K
- Novartis$640
- Astellas Pharma US Inc$153
- AbbVie$75
- Therapeuticsmd, Inc.$70
- Sumitomo Pharma America, Inc.$37
- plus $132 from 7 others
What the payments were for
- Consulting fees$1,64072%
- Food & beverage$59226%
- Education$311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scynexis, Inc. | 3 | $1,157 |
| Novartis | 2 | $640 |
| Astellas Pharma US Inc | 8 | $153 |
| AbbVie | 4 | $75 |
| Therapeuticsmd, Inc. | 3 | $70 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Myovant Sciences Inc. | 2 | $36 |
| Novo Nordisk | 1 | $19 |
| Aspira Women's Health Inc | 1 | $17 |
| Mycovia Pharmaceuticals, Inc. | 1 | $16 |
| Coopersurgical, Inc. | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GILENYA$600
How this compares
$2,263 in reported general payments places this provider in the 70th percentile of 79 gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terconazole | 82 | $1,922 |
| ValacyclovirValacyclovir Hcl | 43 | $1,437 |
| Clindamycin Phosphate | 20 | $995 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $203 |
| Fluconazole | 19 | $65 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Largo
- Vadim MorozovBaltimore$394K
- Andrew LondonLutherville$335K
- Richard MarvelAnnapolis$40K
- Ann PetersBaltimore$25K
- David ZisowForest Hill$24K
- Hector Gonzalez GarciaAnnapolis$23K
- Farinaz SeifiBaltimore$17K
- Christine HelouBaltimore$11K
- Ronald OrleansBethesda$8K
- Parabhdeep GillAnnapolis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.